Pharmaceutical

AstraZeneca champions early kidney disease diagnosis with modelling data

Early diagnosis of chronic kidney disease has both economic and environmental benefits, according to AstraZeneca’s Mina Makar.

Jun 12, 2024 - 04:00
AstraZeneca champions early kidney disease diagnosis with modelling data
Early diagnosis of chronic kidney disease has both economic and environmental benefits, according to AstraZeneca’s Mina Makar.
Read the original article

Tags:

Previous Article

How do supermassive black holes get super massive?

Next Article

Tacalyx extends seed funding round to raise over €14m

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

J&J expands global access to TB drug as popular novelist joins advocacy campaign

J&J expands global access to TB drug as popular novelis...

Jul 14, 2023

STAT+: Here are the worst biopharma CEOs of 2023

STAT+: Here are the worst biopharma CEOs of 2023

Dec 19, 2023

Nuance’s mysterious pricing, speedier digital health evidence reviews, and new breakthrough devices

Nuance’s mysterious pricing, speedier digital health ev...

Jun 2, 2023